Literature DB >> 20457596

Induction and evasion of innate antiviral responses by hepatitis C virus.

Stanley M Lemon1.   

Abstract

Persistent hepatitis C virus infection is associated with progressive hepatic fibrosis and liver cancer. Acute infection evokes several distinct innate immune responses, but these are partially or completely countered by the virus. Hepatitis C virus proteins serve dual functions in replication and immune evasion, acting to disrupt cellular signaling pathways leading to interferon synthesis, subvert Jak-STAT signaling to limit expression of interferon-stimulated genes, and block antiviral activities of interferon-stimulated genes. The net effect is a multilayered evasion of innate immunity, which negatively influences the subsequent development of antigen-specific adaptive immunity, thereby contributing to virus persistence and resistance to therapy.

Entities:  

Mesh:

Year:  2010        PMID: 20457596      PMCID: PMC2906263          DOI: 10.1074/jbc.R109.099556

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  99 in total

Review 1.  The interferons: 50 years after their discovery, there is much more to learn.

Authors:  Sidney Pestka
Journal:  J Biol Chem       Date:  2007-05-14       Impact factor: 5.157

2.  Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes.

Authors:  Kui Li; Zihong Chen; Nobuyuki Kato; Michael Gale; Stanley M Lemon
Journal:  J Biol Chem       Date:  2005-02-28       Impact factor: 5.157

3.  Activation of anti-hepatitis C virus responses via Toll-like receptor 7.

Authors:  Jongdae Lee; Christina C N Wu; Ki Jeong Lee; Tsung-Hsien Chuang; Kyoko Katakura; Yu-Tsueng Liu; Michael Chan; Rommel Tawatao; Michelle Chung; Carol Shen; Howard B Cottam; Michael M C Lai; Eyal Raz; Dennis A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

4.  Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer.

Authors:  Daniel Panne; Tom Maniatis; Stephen C Harrison
Journal:  EMBO J       Date:  2004-10-28       Impact factor: 11.598

5.  Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells.

Authors:  Nan Wang; Yuqiong Liang; Santhana Devaraj; Jie Wang; Stanley M Lemon; Kui Li
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

6.  Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.

Authors:  Jin-Hai Chang; Naoya Kato; Ryosuke Muroyama; Hiroyoshi Taniguchi; Bayasi Guleng; Narayan Dharel; Run-Xuan Shao; Keisuke Tateishi; Amarsanaa Jazag; Takao Kawabe; Masao Omata
Journal:  Liver Int       Date:  2009-10-16       Impact factor: 5.828

7.  MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease.

Authors:  Martin Baril; Marie-Eve Racine; François Penin; Daniel Lamarre
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

8.  Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.

Authors:  N Enomoto; I Sakuma; Y Asahina; M Kurosaki; T Murakami; C Yamamoto; Y Ogura; N Izumi; F Marumo; C Sato
Journal:  N Engl J Med       Date:  1996-01-11       Impact factor: 91.245

9.  Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.

Authors:  Yuqiong Liang; Hisashi Ishida; Oliver Lenz; Tse-I Lin; Origène Nyanguile; Kenny Simmen; Richard B Pyles; Nigel Bourne; Minkyung Yi; Kui Li; Stanley M Lemon
Journal:  Gastroenterology       Date:  2008-07-22       Impact factor: 22.682

10.  Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines.

Authors:  Takayuki Abe; Yuuki Kaname; Itsuki Hamamoto; Yoshimi Tsuda; Xiaoyu Wen; Shuhei Taguwa; Kohji Moriishi; Osamu Takeuchi; Taro Kawai; Tatsuya Kanto; Norio Hayashi; Shizuo Akira; Yoshiharu Matsuura
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

View more
  54 in total

1.  Thematic minireview series: elucidating hepatitis C virus-host interactions at the biochemical level.

Authors:  Charles E Samuel
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 2.  Host genetic basis for hepatitis C virus clearance: a role for blood collection centers.

Authors:  Suganya Selvarajah; Leslie H Tobler; Graham Simmons; Michael P Busch
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

3.  Innate immune response induced by baculovirus attenuates transgene expression in mammalian cells.

Authors:  Chikako Ono; Akinori Ninomiya; Satomi Yamamoto; Takayuki Abe; Xiauyu Wen; Takasuke Fukuhara; Miwa Sasai; Masahiro Yamamoto; Tatsuya Saitoh; Takashi Satoh; Taro Kawai; Ken J Ishii; Shizuo Akira; Toru Okamoto; Yoshiharu Matsuura
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

Review 4.  Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.

Authors:  Ernest T Chivero; Jack T Stapleton
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

5.  Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.

Authors:  Hangfei Qi; Virginia Chu; Nicholas C Wu; Zugen Chen; Shawna Truong; Gurpreet Brar; Sheng-Yao Su; Yushen Du; Vaithilingaraja Arumugaswami; C Anders Olson; Shu-Hua Chen; Chung-Yen Lin; Ting-Ting Wu; Ren Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-03       Impact factor: 11.205

Review 6.  Collaboration of Toll-like and RIG-I-like receptors in human dendritic cells: tRIGgering antiviral innate immune responses.

Authors:  Attila Szabo; Eva Rajnavolgyi
Journal:  Am J Clin Exp Immunol       Date:  2013-10-16

Review 7.  ADARs: viruses and innate immunity.

Authors:  Charles E Samuel
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

8.  HCV infection selectively impairs type I but not type III IFN signaling.

Authors:  Partha K Chandra; Lili Bao; Kyoungsub Song; Fatma M Aboulnasr; Darren P Baker; Nathan Shores; William C Wimley; Shuanghu Liu; Curt H Hagedorn; Serge Y Fuchs; Tong Wu; Luis A Balart; Srikanta Dash
Journal:  Am J Pathol       Date:  2013-11-09       Impact factor: 4.307

Review 9.  Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions.

Authors:  Sreedhar Chinnaswamy
Journal:  J Interferon Cytokine Res       Date:  2014-02-20       Impact factor: 2.607

10.  SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.

Authors:  Bret Poat; Sidhartha Hazari; Partha K Chandra; Feyza Gunduz; Luis A Balart; Xavier Alvarez; Srikanta Dash
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.